# Future Creation Capital

> Future Creation Capital is a VC fund backing Apps and Medical Device. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 9
- Last investment: Oct 2025
- Lead investor: 0%
- Last updated: Aug 2026

Future Creation Capital is a VC fund focused on Apps and Medical Device. Mirai Sozo Capital is the venture capital arm of Mizuho Leasing Company.

## Contacts

5 contacts available for Future Creation Capital. Shizune tracks 1 team members at Future Creation Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mirai-soso-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.8M–$2M |
| Series A | $2.4M–$8.9M |
| Series B | $11M–$12M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Apps | 3 | 33% |
| Medical Device | 3 | 33% |
| Health Care | 2 | 22% |
| News | 1 | 11% |
| Chemical | 1 | 11% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 33% |
| Series A | 2 | 22% |
| Series B | 2 | 22% |
| Funding Round | 1 | 11% |
| Venture - Series Unknown | 1 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Toshihiko Matsuyama | Executive | 3 | https://shizune.co/investors/profile/toshihiko-matsuyama |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OOYOO | OOYOO is a Tech venture, which researches and development of gas separation membranes for carbon dioxide, hydrogen, etc. | $2M | Seed | Oct 15, 2025 |  |
| ARCS | ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology. | $1.8M | Seed | May 12, 2025 |  |
| Aeterlink | Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power. | $12.1M | Series B | Feb 26, 2025 |  |
| Gaudi Clinical | Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments. | $8.9M | Series A | Feb 07, 2025 |  |
| SpeakBuddy | SpeakBUDDY is a web / mobile app development company that believes in "creating something that shouldn't be there now, not something you've seen before". Ourselves solved the difficult English learning problems and released “A serious English conversation! "Lapping English" and "Last English Learning! Twoworks of “Majitan” have won the first place in the AppStore rankings. |  | Venture - Series Unknown | Sep 17, 2024 |  |
| THE PHAGE | The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels. |  | Seed | Sep 12, 2024 |  |
| Spectee | Spectee is a online news agency that specializes in curating and publishing real-time social media UGC video. By using artificial intelligence patented by Spectee, It is able to reduce the time taken to analyze and sort social media news content, giving you faster access to the very latest UGC video. Expect video covering both Japanese andworldwide news from accidents and disasters to lifestyle and entertainment.​ it newsroom is verifying and acquiring licenses of those contents for broadcasters and publishers. | $10M |  | Oct 23, 2023 |  |
| CaTe | CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments. | $10.7M | Series B |  |  |
| KG Motors | KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely by one person. | $2.4M | Series A |  |  |

9 of 9 investments shown.

## Co-investors
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund, 7 deals together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 4 deals together
- [JIC Venture Growth Investments](https://shizune.co/investors/profile/jic-venture-growth-investments) — VC Fund, 2 deals together
- [KISCO](https://shizune.co/investors/profile/kisco) — VC Fund, 2 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 2 deals together
- [Resona Capital](https://shizune.co/investors/profile/resona-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)
- [Automotive VC Funds in Japan](https://shizune.co/investors/automotive-vc-funds-japan)
- [Oil and Gas Investors in Japan](https://shizune.co/investors/oil-and-gas-investors-japan)
- [Oil and Gas VC Funds in Japan](https://shizune.co/investors/oil-and-gas-vc-funds-japan)

## FAQ

### What does Future Creation Capital invest in?

Future Creation Capital invests primarily in Apps, Medical Device and Health Care startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Future Creation Capital's check size?

Future Creation Capital typically joins rounds of $1.8M–$2M at Seed, $2.4M–$8.9M at Series A and $11M–$12M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Future Creation Capital participates in.

### How do I contact Future Creation Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Future Creation Capital?

The team at Future Creation Capital includes Toshihiko Matsuyama (Executive). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co